Alps Global Holding Berhad, a prominent Malaysian healthcare company, has announced its intention to go public through a merger with SPAC Globalink Investment (NASDAQ:GLLI), valuing the company at $1.6 billion.
The combined entity, to be named Alps Life Science, is expected to list on Nasdaq. The transaction is slated to close in Q2 pending shareholder approval.
Under the agreement, Alps shareholders stand to receive up to 48 million additional shares through an earn-out provision if certain milestones are achieved by the combined company. All Alps shareholders will roll 100% of their holdings into the combined company, according to a statement.